3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Spondylarthritis
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Arthritis, Rheumatoid
1
Anemia
1
Interventions
Adalimumab
13
Etanercept
8
Methotrexate
7
Rituximab
6
Abatacept
6
tocilizumab
5
golimumab
5
tofacitinib
4
olokizumab
4
Certolizumab Pegol
4
Tumor Necrosis Factor Inhibitors
3
Infliximab
3
Saline Solution
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Sodium Chloride
1
Radioimmunodetection
1
RC-18
1
Pharmaceutical Preparations
1
Lysine Acetyltransferase 5
1
Leflunomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Rheumatoid
×
Radioimmunodetection
×
Clear all
NCT01590966
2019-08-26
SCINTRA
University Hospital, Ghent
Phase 3
Completed
41 enrolled